Why you should consider banking your baby’s cord blood
Cord blood is the leftover blood in the umbilical cord after birth, and cord tissue is the cord itself. Both contain powerful stem cells that could be used to potentially treat a variety of medical conditions. Cord blood is rich in stem cells that can morph into all sorts of blood cells, which can be used to treat diseases that harm the blood and immune system, such as leukemia and certain cancers, sickle-cell anemia, some metabolic disorders, etc. They can help treat over 80 conditions today, plus there’s research in progress for more potential uses.
Cord tissue stem cells are also showing a lot of promise in regenerative medicine like brain injuries, osteoarthritis, cardiovascular disease and autoimmune diseases like lupus.
If you are interested, here’s how it works
You have to make the decision to go for it before birth because you will need a collection kit. These cells only get the chance of being collected right at birth.
1. Order your kit
Choose your product, order online and create your account with some basic information. We’ll be glad to help with any questions. Your kit will then arrive within 3 days. Express shipping is available.
2. Welcome new life
Contact us when you go into labour. Your kit contains everything needed for your cord blood and/or tissue collection. We organise your courier so you can focus on your new baby.
3. Protect your future
We’ll let you know your stem cell count and viability before storing your samples for your chosen period. Stay up-to-date with stem cells news of our website and if you ever need us, don’t hesitate to call.
These cells are a 100% match to baby, and siblings have a 75% chance to be a full or partial match.
These cells then are placed in a medical freezer and, just like freezing your eggs, they can be used for decades to come since it stops the clock on aging of the cells.
If you decide to go for it but you’d like to know more, please don’t hesitate to get in touch 01752 753 723 or email email@example.com
BSc (Hons) Microbiology
Biovault Family CEO, Kate Sneddon, joined Biovault in July 2009 and became Chief Executive Officer in 2016. As health industry professional her experience includes working as a microbiologist and leader at GSK for over 10 years. Her expertise in cord blood banking has been recognised in her awards, features in Parliamentary Review and Parents Guide to Cord Blood, as well as contributions to research with UCL and others.